InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.16
(
0.47%
)
US TECH 100
18,024.00
(
0.56%
)
Dow Jones
39,497.54
(
0.13%
)
Brent Oil
79.49
(
0.00%
)
Bitcoin
60,632.67
(
-0.40%
)
Post# of 21127
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

knoxweb1

Send PM Follow Ignore
Followers 2
Posts 1112
Boards Moderated 0
Alias Born 12/30/2010

knoxweb1

Re: None

Tuesday, 03/13/2012 4:03:05 PM

Tuesday, March 13, 2012 4:03:05 PM

Post# of 21127
ALZHEIMER’S DISEASE

BioGeron Inc. is committed to the discovery of a non-prescription supplement that can be used for the prevention or delay of the early stages of Alzheimer’s Disease (AD), which includes developing a treatment for Mild Cognitive Impairment (MCI) and other conditions generally associated with the final stages of memory loss.

Additionally, the company plans to release another six formulas within the next year under their LifeExtenz Plus product line. Formulas planned to be released include Healthy Heart, Memory Plus, Bone Health, Immunity Plus, and several others.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up